Evidence map›Paper›PMID 40457361›Full record

ArticleImplementation science communications2025

Getting to Implementation for HIV Pre-Exposure Prophylaxis (GTI-PrEP): A data-driven approach to PrEP prescribing.

Shari S Rogal, Brittney Neely, Monica Merante, Karen Slazinski, Lorenzo McFarland, Christina Brodkorb, Jada Cooper, Carolyn Lamorte, Sandra Gibson, Emily Comstock and 8 more

Abstract read
In one paragraph

Article in Implementation science communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Shari S RogalCenter for Health Equity Research and Promotion, VA Pittsburgh Healthcare System, Pittsburgh, PA, USA. rogalss@upmc.edu.ORCID http://orcid.org/0000-0001-8184-1546
Brittney NeelyCenter for Health Equity Research and Promotion, VA Pittsburgh Healthcare System, Pittsburgh, PA, USA.
Monica MeranteCenter for Health Equity Research and Promotion, VA Pittsburgh Healthcare System, Pittsburgh, PA, USA.
Karen SlazinskiInfectious Diseases Section, Orlando VA Medical Center, Orlando, FL, USA.
Lorenzo McFarlandOffice of Specialty Care Services, Department of Veterans Affairs, HIV, Hepatitis, and Related Conditions, Washington, DC, USA.
Christina BrodkorbGulf Coast Veterans Health Care System, Biloxi, MS, USA.
Jada CooperGulf Coast Veterans Health Care System, Biloxi, MS, USA.
Carolyn LamorteCenter for Health Equity Research and Promotion, VA Pittsburgh Healthcare System, Pittsburgh, PA, USA.
Sandra GibsonCenter for Health Equity Research and Promotion, VA Pittsburgh Healthcare System, Pittsburgh, PA, USA.
Emily ComstockInfectious Diseases Section, Baltimore VA Medical Center, Baltimore, MD, USA.
Jamie MoranoOffice of Specialty Care Services, Department of Veterans Affairs, HIV, Hepatitis, and Related Conditions, Washington, DC, USA.
Marissa MaierInfectious Diseases Section, VA Portland Health Care System, Portland, OR, USA.
Lauren A BesteGeneral Medicine Service, Puget Sound VA Healthcare System, Seattle, WA, USA.
Karine RozenbergVA Great Lakes Health Care System, VISN 12 Pharmacy Benefits Management, Westchester, IL, USA.
Maggie ChartierOffice of Specialty Care Services, Veterans Health Administration, Washington, DC, USA.
Matthew J ChinmanCenter for Health Equity Research and Promotion, VA Pittsburgh Healthcare System, Pittsburgh, PA, USA.
David RossOffice of Specialty Care Services, Department of Veterans Affairs, HIV, Hepatitis, and Related Conditions, Washington, DC, USA.
Vera YakovchenkoCenter for Health Equity Research and Promotion, VA Pittsburgh Healthcare System, Pittsburgh, PA, USA.

Funding

Improving Pain Management and Opioid Safety for Patients with CirrhosisK23DA048182 · NIDA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI ROGAL, SHARI S · 2020 to 2023
$755k
HSRD VA IK6 HX003767Intramural Research Program, National Institute on Drug Abuse K23DA048182NIDA NIH HHS K23 DA048182Quality Enhancement Research Initiative PEC 19-307
6 · The paper itself

Abstract

backgroundPre-Exposure Prophylaxis (PrEP) dramatically reduces the likelihood of acquiring human immunodeficiency virus (HIV), yet it remains under-prescribed, particularly for people in communities with high HIV incidence. While implementation science and health services researchers aim to address disparities in care, few interventions have proven effective in doing so. We aimed to identify implementation strategies associated with higher PrEP prescribing rates and pilot test a tailored intervention as a proof-of-concept in a single Veterans Health Administration (VA) facility.

methodsVA clinicians were surveyed using an instrument derived from the Evidence-based Recommendations for Implementing Change taxonomy to assess the use of various strategies for PrEP in fiscal years 2019-2021. Correlational analyses identified the strategies associated with the frequency of PrEP prescribing and semi-structured interviews with personnel from 11 VA medical facilities with high PrEP prescribing refined and manualized these strategies into the Getting to Implementation (GTI)-PrEP playbook. The playbook was subsequently pilot tested in a VA facility with high new HIV diagnosis rates and low PrEP prescribing rates.

resultsThe clinician survey collected 157 responses from 95 unique VA facilities on implementation strategy use. Analysis identified eight strategies significantly associated with PrEP prescribing, including: networking, clinician education, clinical support tools, dashboard utilization, telehealth, pharmacist involvement, direct patient engagement, and enhanced sexual health history taking. In the pilot study, the site completed the GTI-PrEP Playbook with high fidelity and newly implemented seven of the eight strategies, achieving a 363% increase in PrEP prescribing rates among Black Veterans over the one-year period.

conclusionsThis multi-year national evaluation identified a core subset of effective implementation strategies for increasing PrEP prescribing. The process of empirically specifying these strategies and pilot testing them through the GTI-PrEP playbook demonstrates a promising, data-driven approach to improve PrEP prescribing rates and reduce racial disparities in HIV prevention.

Indexed as

Healthcare deliveryHIV/AIDSImplementationPre-exposure prophylaxisPreventionStrategies

Identifiers

PMID40457361
PMCPMC12131467

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.